Purchase Order 75D30123P17302
Award Date
7/31/23
Potential Completion Date
8/30/23
Potential Value
$205K
Federal Agency
CDC Pittsburgh
Awardee
Qiagen, LLC
Ultimate Awardee
Qiagen N.V.
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $32,000 purchase order to Qiagen, LLC for a QIAGEN ROBOT. Qiagen, LLC is a division of Qiagen N.V., which will serve as the prime contractor to deliver the robotic system to the CDC location in Germantown, Maryland between September 12-29, 2023. The contract has a firm fixed price and will support the CDC's efforts to modernize its laboratory equipment and processes. No major...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $134,109.65 purchase order to Qiagen, LLC for laboratory supplies. Qiagen, LLC is a division of Qiagen N.V., which will serve as the prime contractor. The contract has a firm fixed price and period of performance from July 25, 2023 through July 25, 2024. No additional details were provided on the requested products or services, however based on the funding agency, the laboratory...
Qiagen, LLC was awarded a purchase order for $66,592.30 by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to provide EZ1 & 2 DNA Tissue Kits, Buffer AL, and Qiagen Proteinase K. No set-aside designation was applied to this contract. Performance will take place in Germantown, Maryland through August 31, 2023. Qiagen, a division of Qiagen N.V., will deliver the requested DNA extraction products to support the Centers for Disease Control and...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $79,796.08 firm-fixed-price purchase order to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract is for the purchase of a QIAGEN EZ2 Connect MDX system. This equipment will support the CDC's biomedical research, public health, and healthcare programs. Qiagen has provided a range of laboratory products and services to various federal agencies in the past, including the Department of Health...
Qiagen, LLC has been awarded a $50,809.30 firm fixed price purchase order by the Department of Health and Human Services Centers for Disease Control and Prevention located in Pittsburgh, Pennsylvania. The award is for the delivery of QIACUBE HT/QIAXTRACTOR platforms and reagents to support the agency's biomedical research and public health programs. No set-aside designation was applied to this procurement. Performance will take place in Germantown, Maryland by Qiagen, a division of Qiagen...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $82,823.10 firm fixed price purchase order to Qiagen, LLC, a division of Qiagen N.V., for the EZ2 CONNECT MDX SYSTEM FUL-3. This system supports the CDC's biomedical research, public health, and healthcare programs. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academia. The contract has no set-aside designation and is scheduled for completion by...
This federal contract award with ID 75D30124P19812 was issued by the Centers for Disease Control and Prevention (CDC) in Pittsburgh to Qiagen, LLC, a division of the international diagnostics company Qiagen N.V. The $219,630.87 firm fixed-price purchase order is for Qiagen's EZ2 CONNECT MDX IVD Extraction System, a sample preparation device used in molecular diagnostics. The contract has a period of performance through November 27, 2024. Qiagen has provided a range of products and services to...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a firm fixed price purchase order valued at approximately $8,721 to Qiagen, LLC for the delivery of TISSUELYSER LT laboratory equipment. As a division of Qiagen N.V., Qiagen will perform as the prime contractor under the contract to provide the requested products and services. The place of performance will be Qiagen's Germantown, Maryland facility. The period of performance spans from...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $60,250.00 firm fixed price purchase order contract to Qiagen, LLC, a division of the parent company Qiagen N.V. The contract has an ultimate completion date of September 28, 2024 and was awarded on September 29, 2023. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academics. This contract does not have a set-aside designation. Qiagen has...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $57,348.26 firm fixed-price purchase order contract to Qiagen, LLC, a division of the international provider Qiagen N.V., for QIACUITY equipment and maintenance services. This contract does not have a set-aside designation. Qiagen has a history of providing products and services, such as DNA/RNA extraction kits, next-generation sequencing, and bioinformatics software, to support federal agencies'...